Cell Mass Increase Associated with Formation of Glucose‐Controlling β‐Cell Mass in Device‐Encapsulated Implants of hiPS‐Derived Pancreatic Endoderm

Device‐encapsulated human stem cell‐derived pancreatic endoderm (PE) can generate functional β‐cell implants in the subcutis of mice, which has led to the start of clinical studies in type 1 diabetes. Assessment of the formed functional β‐cell mass (FBM) and its correlation with in vivo metabolic ma...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Stem Cells Transl Med
Auteurs principaux: Robert, Thomas, De Mesmaeker, Ines, Van Hulle, Freya O., Suenens, Krista G., Stangé, Geert M., Ling, Zhidong, Haller, Corinne, Bouche, Nicolas, Keymeulen, Bart, Kraus, Marine R.C., Pipeleers, Daniel G.
Format: Artigo
Langue:Inglês
Publié: John Wiley & Sons, Inc. 2019
Sujets:
Tissue Engineering and Regenerative Medicine
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6877770/
https://ncbi.nlm.nih.gov/pubmed/31379140
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sctm.19-0043
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires